Related Experiment Video
Updated: Jul 4, 2025
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Risk of Multidrug-Resistant Pathogens in Severe Community-Acquired Pneumonia
E Campaña-Duel1,2, M Camprubí-Rimblas1,2, A Areny-Balagueró1,2
1Critical Care Center, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain.
Abstract:
Severe community-acquired pneumonia (SCAP) is difficult to treat when caused by difficult-to-treat (DTR) pathogens because of limited treatment options and poorer clinical outcomes. Over time, several predictive scoring systems based on risk factors for infection with multidrug resistant pathogens have been developed. We reviewed the available tools for identifying DTR pathogens as the cause of SCAP, both predictive scoring systems and rapid diagnostic methods, to develop management strategies aimed at early identification of DTR pathogens, reducing broad-spectrum antibiotic use and improving clinical outcomes. The scoring systems reviewed show considerable heterogeneity among them at the level of the region studied, the definition of risk factors, as well as which DTR pathogens are the target pathogens. The models described have shown limited effectiveness in reducing inappropriate antibiotic treatment or improving patient outcomes by themselves. However, predictive models could serve as a first step in identifying DTR pathogen infections as part of a larger detection algorithm. Rapid diagnostic tools, such as multiplex polymerase chain reaction, would be useful for the rapid identification of pneumonia-causing pathogens and their resistance mechanisms. In resource-limited settings, rapid tests should be limited to patients at high risk of developing SCAP due to DTR pathogens. We propose an integrative algorithm based on the different scores, taking into account local epidemiological data, where ideally each center should have an antimicrobial stewardship program.
Insights
Identifying difficult-to-treat pathogens causing severe community-acquired pneumonia (SCAP) requires better tools. An integrated approach using predictive scores and rapid diagnostics can improve treatment and outcomes.
Area of Science:
- Infectious Diseases
- Pulmonology
- Antimicrobial Resistance
Background:
- Severe community-acquired pneumonia (SCAP) poses treatment challenges due to difficult-to-treat (DTR) pathogens, leading to limited options and poor outcomes.
- Existing predictive scoring systems for DTR pathogens in SCAP exhibit significant heterogeneity in methodology and target pathogens.
- Current models demonstrate limited standalone effectiveness in reducing inappropriate antibiotic use or improving patient outcomes.
Approach:
- A comprehensive review of predictive scoring systems and rapid diagnostic methods for identifying DTR pathogens in SCAP was conducted.
- The review aimed to inform management strategies for early DTR pathogen detection, reduced broad-spectrum antibiotic use, and improved clinical outcomes.
- An integrative algorithm combining predictive scores, local epidemiology, and rapid diagnostics is proposed.
Key Points:
- Predictive scoring systems for DTR pathogens in SCAP show variability and limited effectiveness individually.
- Rapid diagnostic tools, like multiplex PCR, are crucial for swift pathogen and resistance mechanism identification.
- In resource-limited settings, rapid tests should be prioritized for high-risk SCAP patients.
Conclusions:
- An integrated algorithm incorporating predictive scores and rapid diagnostics is essential for managing SCAP caused by DTR pathogens.
- Local epidemiological data and antimicrobial stewardship programs are vital components of effective management strategies.
- Optimizing diagnostic and treatment pathways can lead to improved clinical outcomes for SCAP patients.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
03:53Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....